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Abstract
Background: Protogenin (Prtg) has been identified as a gene which is highly expressed in the mouse mandible at
embryonic day 10.5 (E10.5) by a cDNA subtraction method between mandibles at E10.5 and E12.0. Prtg is a new
member of the deleted in colorectal carcinoma (DCC) family, which is composed of DCC, Neogenin, Punc and
Nope. Although these members play an important role in the development of the embryonic central nervous
system, recent research has also shed on the non-neuronal organization. However, very little is known regarding
the fetal requirement of the non-neuronal organization for Prtg and how this may be associated with the tooth
germ development. This study examined the functional implications of Prtg in the developing tooth germ of the
mouse lower first molar.
Results: Ptrg is preferentially expressed in the early stage of organogenesis. Prtg mRNA and protein were widely
expressed in the mesenchymal cells in the mandible at E10.5. The oral epithelial cells were also positive for Prtg.
The expression intensity of Prtg after E12.0 was markedly reduced in the mesenchymal cells of the mandible, and
was restricted to the area where the tooth bud was likely to be formed. Signals were also observed in the
epithelial cells of the tooth germ. Weak signals were observed in the inner enamel epithelial cells at E16.0 and
E18.0. An inhibition assay using a hemagglutinating virus of Japan-liposome containing Prtg antisense-
phosphorothioated-oligodeoxynucleotide (AS-S-ODN) in cultured mandibles at E10.5 showed a significant growth
inhibition in the tooth germ. The relationship between Prtg and the odontogenesis-related genes was examined in
mouse E10.5 mandible, and we verified that the Bmp-4 expression had significantly been decreased in the mouse
E10.5 mandible 24 hr after treatment with Prtg AS-S-ODN.
Conclusion: These results indicated that the Prtg might be related to the initial morphogenesis of the tooth germ
leading to the differentiation of the inner enamel epithelial cells in the mouse lower first molar. A better
understanding of the Prtg function might thus play a critical role in revealing a precious mechanism in tooth germ
development.
Background
The organs of vertebrates are typically composed of
epithelial and mesenchymal tissues. Signaling between
these two tissues governs many aspects of organogen-
esis, from the initiation of organ development to the
terminal differentiation of organ-specific cell types. The
development and differentiation of the mouse tooth
germ, like many other organs, depends on such induc-
tive interactions. A large number of genes have been
proven to be related to tooth morphogenesis [1-8].
However, the precise signaling pathway which is
involved in the initiation, growth, and differentiation of
the tooth germ has not yet been fully elucidated. There
may be additional odontogenesis-related genes that have
not yet been identified. A cDNA subtraction between
the mandibles of embryonic day 10.5 (E10.5) and E12.0
mice was conducted to identify genes which might be
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highly expressed positive clones were obtained from the
E10.5 mandible by a colony array screening. In addition,
47 of the highly expressed positive clones were also
obtained from the E12.0 mandible [9]. The expression
of several of those genes is closely associated with the
developing tooth germ [7,8,10-12]. Protogenin (Prtg)
[13,14], which we first designated as Clone 15,i so n eo f
t h eh i g h l ye x p r e s s e dg e n e si nt h em o u s em a n d i b l ea t
E10.5 [9].
Prtg belongs to the immunoglobulin superfamily
(IgSF), which is one of the largest protein families in the
mammalian genome [15,16]. This family is comprised of
transmembrane and cell surface proteins and its mem-
bers are characterized by immunoglobulin (Ig) domains
in their extracellular regions. The IgSF members act as
adhesion molecules, and can also transduce signals upon
ligand stimulation. Many members of the IgSF are
involved in tissue formation and morphogenesis during
embryonic development [15,16]. However, thus far the
functions of Prtg have not been elucidated.
The constituents of a subgroup of the IgSF have
recently received attention because of their roles in the
migration and guidance of axon growth during develop-
ment of the vertebrate nervous system. One of the
representative genes in this subgroup is the Deleted in
Colorectal Cancer (DCC) gene, and therefore this sub-
group is referred to DEAL (DCC et al.), and includes
DCC, Neogenin [17], Punc [18], and Nope [19]. DCC
was originally identified as a tumor suppresser gene
[20], but it has been recently shown to act as a Netrin
receptor for cell migration and axon guidance cues [19].
Like DCC, Neogenin is a Netrin receptor. Punc [21] and
Nope are prominently expressed by differentiating neu-
rons in the central nervous system. They are involved in
the early stages of nerve tissue morphogenesis. Prtg
belongs to DEAL because their structures are highly
homologous. There are two reports in which the expres-
sion of Prtg was described in chick [13], mouse, and
zebrafish [14]. These reports demonstrated that Prtg is
expressed in the central nervous system in the early
developmental stages of the embryo. Vesque et al. [14]
demonstrated that this gene is expressed in the first
branchial arch as well as in the central nervous system.
This finding supported a previous study [9] in which
Prtg was preferentially expressed in the first branchial
arch prior to tooth germ formation. Therefore, it is pos-
sible that the Prtg gene is related to the morphogenesis
of the tooth germ because the tooth germ develops
under the influence of cells in the first branchial arch.
This study characterized the expression pattern of Prtg
in the developing tooth germ, and examines the possible
functional implications of this gene in tooth germ
morphogenesis.
Results
Characterization of predicted Prtg protein
A DNA sequence analysis was performed by using of
the 5’-RACE and 3’-RACE methods. Based on the DNA
sequence analysis, the Prtg protein comprises 1191
amino acids, a signal peptide (SP), 4 Ig domains, 5 fibro-
nectin (FN)-type III repeats, a single transmembrane
(TM), and a cytoplasmic domain (CD). The deduced
molecular structure is shown in Figure 1. In sequencing
the five independent Prtg cDNA clones from E10.5
mice, no alternatively spliced variant was found within
the coding region of the amino acids.
Full-length (Prtg-full) cDNA and mutant cDNA with a
complete deletion of the SP region were inserted into an
enhanced green fluorescent protein (EGFP) (Clontech)
vector, and was then transfected into MISK81-5 cells,
which is an oral squamous cell carcinoma cell line
established in our laboratory [22], to characterize the
intracellular localization of the Prtg protein. The
MISK81-5 cells transfected with Prtg-full showed a loca-
lization of EGFP-fusion protein in the cell membrane by
fluorescence microscopy (Figure 2B). Meanwhile, the
other transfectants with Ptrg-ΔSP1, Prtg-ΔSP2, or empty
vector showed a diffuse intracellular Prtg distribution
(Figure 2B). Immunofluorescent staining for cadherin, a
marker of the cell membrane-associated protein, in the
transfectants with Prtg-full showed that the fluorescence
images of Prtg-EGFP fusion protein and cadherin were
merged (Figure 2C). These results indicated that Prtg
was localized in the cell membrane.
A Western blot analysis using a Prtg affinity polyclo-
nal anti-body demonstrated the molecular mass (Mr)o f
Prtg to be 180 kDa (Figure 3, lane 2). The mature
Figure 1 Prtg has a characteristic domain structure and
putative glycosylation sites in the extracellular region. The Prtg
protein contains a signal peptide, Ig domains, five fibronectin-type
III (FNIII) repeats, a single transmembrane (TM), and a cytoplasmic
domain (CD). The structure indicates a high similarity to Nope. The
circles indicate glycosylated sites.
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Page 2 of 15mouse Prtg contains 1191 amino acids, and therefore
the estimated Mr is approximately 130 kDa. Because the
molecules which have SP in the extracellular domain
(ECD) are often highly glycosylated, it is thought that
differences in Mr m i g h tb ec a u s e db yg l y c o s y l a t i o na t
the ECD (Figure 1). Prtg protein was purified from the
mandible at E10.5, and was treated with N-glycosidase F
and assayed by an immunoblotting analysis to confirm
ECD glycosylation and to identify the accurate size of
Prtg. A Western blot analysis after the treatment of
N-glycosidase F showed a reduced Prtg size (Figure 3,
lane 3).
Temporal expression analysis of Prtg mRNA and protein
during odontogenesis
Because Prtg was highly expressed in the mouse mandible
at E10.5 [9], the temporal expression pattern of the Prtg
mRNA during embryogenesis was examined by semi-
quantitative RT-PCR with the total RNA from whole
embryos. Prtg is highly expressed at E10.5 (Figure 4A).
Figure 2 Ptrg is a transmembrane protein. (A) The constructs expressing various Prtg-EGFP fusion proteins are represented by a schematic
drawing. The circled numbers refer to the amino acids position from methionine (M) at the initiation site of protein translation. (B) The
recombinant Prtg-EGFP fusion protein is detected along the cell surface (Prtg-full), whereas the SP-deleted Prtg-EGFP fusion protein is present in
pools in the cytoplasm of cells transfected with Ptrg-ΔSP1 or Prtg-ΔSP2. (C) Immunofluorescent signals for cadherin (red) overlap with the
localization of the Prtg-EGFP fusion proteins in the transfected cells. The nuclei are counterstained by DAPI.
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mRNA in the whole body at E14.0 and E18.0 (Figure 4A).
Thereafter, the Prtg mRNA expression was examined in
adult organs, and compared to the expression level of the
E10.5 embryo. A weak expression was demonstrated in
the central nervous system of the adult mice. Meanwhile,
no expression was detected in the other organs (Figure
4B). These results indicated that Prtg mRNA is primarily
expressed at the early-middle stages of embryogenesis
[13,14].
The expression level of Prtg protein in the mouse
mandible was also examined by a Western blotting ana-
lysis. As shown in Figure 4C, the Prtg protein levels in
the mandible were higher at E10.5 than that at E12.0.
The Prtg mRNA levels also decrease in the E12.0 mand-
ible compared to the E10.5 mandible in the cDNA sub-
traction analysis [9]. The expression level of the Prtg
protein was dramatically reduced in the tooth germ at
E18.0 (Figure 4C).
Figure 3 Ptrg is a highly N-glycosylated protein. A Western blot
analysis revealed that Prtg purified from an E10.5 mandible is a
protein with a molecular mass of approximately 180 kDa (lane #2).
The molecular mass is much larger than that calculated from the
predicted amino acid sequences. N-glycosidase F reduces the size of
the proteins to approximately 130 kDa (lane #3). The purified proteins
were separated and stained with Coomassie brilliant Blue dye (lane
#1). The amount of the loaded protein is 10 μg in each lane.
Figure 4 Prtg is preferentially expressed in the early stage of organogenesis. A semi-quantitative RT-PCR analysis of Prtg is compared at
various embryonic stages and in various organs of postnatal mice. (A) As development proceeded from E10.5 to E14.0, the Prtg transcripts were
dramatically decreased in the whole body. (B) In the postnatal mice, Prtg transcripts were detected only in the brain of the 10-week-old mice.
However, they were remarkably reduced in comparison with that in the E10.5 whole body. Each organ group is represented by two samples. (C)
According to an immunoblotting analysis, Prtg is expressed at substantially higher levels in the E10.5 mandible than in the E12.0 mandible. Prtg
was dramatically decreased in the tooth germ at E18.0. The amount of the loaded protein is 10 μg in each lane.
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Page 4 of 15Expression of the Prtg mRNA and protein in the
developing tooth germ and other organs
An in situ hybridization analysis was performed by using
a Prtg antisense cRNA probe to examine the temporal
and spatial expression pattern of the Prtg mRNA in the
course of the developing mouse embryonal organs. In
situ hybridization (ISH) for Prtg mRNA showed diverse
signal intensity within the same tissue section. There-
fore, the terms ‘’strong’’ and ‘’weak’’ were used only for
the relative evaluation of the signal intensity in the same
section.
The whole mount in situ expression of the Prtg
mRNA at E10.5 revealed that this signal was present in
the maxilla and mandible as well as central nervous sys-
tem and eye, and thus the expression pattern of Prtg
mRNA seemed to correspond to the distribution of the
arch ectodermal cells (Figures 5A and 5B). This
appeared to be similar to the results of the study by
Vesque et al. [14]. In addition, in the study by Chai et
al. [23], the Prtg function appeared to be involved in the
cranial neural crest cells. At E10.5, a strong expression
of in situ signal of Prtg w a ss e e ni nt h em e s e n c h y m a l
cells which were widely distributed in the first branchial
arch including the developing mandible (Figure 5C).
A signal was also found throughout the oral epithelial
layer. At E12.0, in situ signal was observed in the oral
epithelial layer, including the thickened area and under-
lying mesenchymal cells (Figure 5D). At E14.0, the Prtg
mRNA signal was rather restricted to the enamel organ
and the dental mesenchyme (Figure 5F). At E16.0, in
situ signal of Prtg was detected in the enamel organ, in
the dental papilla and in the dental sac (Figure 5G), but
the intensity appeared to be reduced. At E18.0, a faint
in situ signal of Prtg was found in the inner enamel
epithelium. The faintly positive cells were localized in
the presumptive cuspal areas. Weak mRNA expression
was also observed in the outer enamel epithelium. How-
ever, the in situ signal was markedly reduced in the den-
tal papilla (Figure 5H). A Prtg sense probe was applied
to the tissue specimens as a control. However, no hybri-
dization signal was detected (Figures 5E and 5I).
An immunohistochemical analysis (IHC) was also car-
ried out using an anti-Prtg antibody. Both the protein
expression and gene expression were detected in the
first branchial arch in a widespread pattern, in both the
epithelium and mesenchyme. Strong signals were noted
near the oral epithelial layer (Figure 6A). A higher mag-
nification showed the immunohistochemical signal of
the Prtg protein to be observed surrounding the cells
with a punctate appearance (Figure 6B), suggesting pro-
tein localization on the cell surface. This staining pat-
tern was common in all the sections of each embryonic
day. Although immunolocalization of the protein was
present in both the epithelium and mesenchyme at
E12.0, the signal intensity was reduced in comparison to
that at E10.5 (Figures 6C and 6D). At E14.0, the Prtg
protein signal was conspicuously detected in the enamel
organ and the surrounding condensed mesenchymal
cells (Figures 6E and 6F). The signal in the epithelium
was stronger than that in the mesenchyme. At E16.0,
immunohistochemical signal of Prtg were marginally
detected in the enamel organ and in the dental papilla
(Figures 6G and 6H). At E18.0, a faint immunohisto-
chemical signal was detected in the inner and outer
enamel epithelia, and in the dental papilla (Figures 6I
and 6J).
Thus, both the mRNA and protein of Prtg demon-
strated similar expression patterns during odontogenesis.
In addition, the expression of Prtg is localized in the
developing nervous system, especially in the neural tube,
the retina, the lens, and the brain throughout the
embryonic period.
Functional analysis of Prtg during development of the
tooth germ
The results of the in situ hybridization and immunohisto-
chemical analyses suggested that Prtg might be involved
in tooth morphogenesis. Therefore, an inhibition assay
for the translation of Prtg mRNA was performed using
Prtg antisense-phosphorothioated-oligodeoxynucleotide
(AS-S-ODN) according to the same experimental design
in our previous studies [6,7].
The expression of Prtg was time-dependently exam-
ined in the organ-cultured E10.5 mandibles because the
expression level of Prtg markedly decreased after E12.0
in comparison to that at E10.5 (shown in the Figures 4A
and 4C). The real-time PCR showed a marked decrease
of the Prtg expression by 48 hr in mandible culture (Fig-
ure 7A) as well as that in E10.5 and E12.0 mandibles
(Figure 7B). The Prtg expression in the mandibles cul-
tured for 24 hr and 48 hr significantly decreased to less
than 40% and 15% of that in the E10.5 mandible, respec-
tively. The Prtg expression in the E12.0 mandible also
showed a marked reduction to less than 5% of that in
the E10.5 mandible.
A histological analysis was performed to evaluate the
effects of Prtg knockdown on enamel organ formation in
the cultured E10.5 mandible after phosphorothioated-
oligodeoxynucleotide (S-ODN) treatment for 8 days. The
period of organ culture was based on previous studies
[6,7] in which the normal development of the tooth germ
showed the cap stage by the 8th day of organ culture. As
shown in Table 1, most of the cultured mandibles at
E10.5 treated with Prtg AS-S-ODN showed an apparent
inhibition of tooth germ development after being cul-
tured for 8 days (Figure 7D and Table 1). In contrast, the
mandibles treated with Prtg sense-S-ODN (SE-S-ODN)
showed normal cap-like tooth germ (Figure 7C) as did
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Page 5 of 15Figure 5 In situ signal of Prtg mRNA is noted in the developing tooth germ. (A) The whole mount in situ expression in an E10.5 embryo
reveals that Prtg mRNA is present in the maxilla and mandible as well as in the central nervous system. (B) A higher magnification of Fig. 5A;
mx, maxilla; md, mandible. (C) At E10.5, strong in situ Prtg signals were present in the mesenchymal cells in the first branchial arch and
throughout the oral epithelial layer (OPL). (D) At E12.0, an in situ signal is observed in the OPL and underlying mesenchymal cells. (E) Control
section with sense probe to Fig. 5D. (F) At E14.0, the Prtg mRNA is conspicuous in the enamel organ and the surrounding mesenchymal cells.
(G) At E16.0, in situ signals are detected in the enamel organ and the dental papilla. (H) At E18.0, a faint mRNA signal is marginally detected in
the inner enamel epithelium. In the dental papilla, the positive cells are noted in the presumptive caspal areas. The signal is undetectable in the
other areas. (I) Control section with sense probe in an E18.0 tooth germ. The left side of Figs. 5C-H corresponds to the lingual side, and the right
side is the buccal side. Scale bars: C- H, 200 μm.
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Page 6 of 15Figure 6 Prtg knockdown induces arrest of the tooth germ development. (A) Prtg transcripts were dramatically decreased in the E10.5
mandible in a time-dependent manner in the organ culture (** p < 0.01). (B) Prtg expression in the E12.0 mandible was reduced to less than
5% of that in the E10.5 mandible (** p < 0.01). Tooth germ in the control sample or in the mandible treated with SE-S-ODN (C) developed to
the cap stage on the 8th day of cultivation, while (D) an arrest of the tooth germ development was observed in samples treated with the AS-S-
ODN. Immunohistochemically, Ki67-positive cells were seen in the control samples and in the mandibles treated with SE-S-ODN (E), and in
samples treated with AS-S-ODN (F) on the 8th day after cultivation. (G) There were no significant differences in the cell proliferation in the
objective areas among the control samples, the samples treated with AS-S-ODN and the samples treated with SE-S-ODN. Significant differences
in the cell proliferation were noted between the DE and SM in the control samples and in the mandible treated with SE-S-ODN, while this was
not observed among the areas in samples treated with AS-S-ODN (*p < 0.05, ** p < 0.01). The left sides of Figures 6C, D, E and F correspond to
the buccal side, while the right side corresponds to the lingual side. Scale bars: C, D, E and F, 150 &#956m. Ut; untreated control sample, AS;
samples treated with AS-S-ODN, SE; samples treated with SE-S-ODN. DE; dental epithelium, DM; dental mesenchyme, SM; surrounding
mesenchyme (SM).
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Page 7 of 15Figure 7 Prtg knockdown induces arrest of the tooth germ development. (A) Prtg transcripts were dramatically decreased in the E10.5
mandible in a time-dependent manner in the organ culture (** p < 0.01). (B) Prtg expression in the E12.0 mandible was reduced to less than
5% of that in the E10.5 mandible (** p < 0.01). Tooth germ in the control sample or in the mandible treated with SE-S-ODN (C) developed to
the cap stage on the 8th day of cultivation, while (D) an arrest of the tooth germ development was observed in samples treated with the AS-S-
ODN. Immunohistochemically, Ki67-positive cells were seen in the control samples and in the mandibles treated with SE-S-ODN (E), and in
samples treated with AS-S-ODN (F) on the 8th day after cultivation. (G) There were no significant differences in the cell proliferation in the
objective areas among the control samples, the samples treated with AS-S-ODN and the samples treated with SE-S-ODN. Significant differences
in the cell proliferation were noted between the DE and SM in the control samples and in the mandible treated with SE-S-ODN, while this was
not observed among the areas in samples treated with AS-S-ODN (*p < 0.05, ** p < 0.01). The left sides of Figures 7C, D, E and F correspond to
the buccal side, while the right side corresponds to the lingual side. Scale bars: C, D, E and F, 150 μm. Ut; untreated control sample, AS; samples
treated with AS-S-ODN, SE; samples treated with SE-S-ODN. DE; dental epithelium, DM; dental mesenchyme, SM; surrounding mesenchyme (SM).
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Page 8 of 15the untreated mandibles and mandibles treated with only
hemagglutinating virus of Japan (HVJ)-liposome (Table
1). The development of the enamel organs treated with
Prtg AS-S-ODN on day 8 of culture was significantly
inhibited in comparison to that in the other groups (p <
0.05; Table 1).
A cell proliferation analysis was performed to address
the involvement of Prtg in the tooth morphogenesis.
The Ki67-positive ratio was evaluated in the cultured
organs treated with AS-S-ODN for Prtg. In the cultured
organs, the objective cells were examined in three areas;
the “dental epithelium (DE)”, “dental mesenchyme
(DM)” and “surrounding mesenchyme (SM)”.T h eD M
was either the “dental papilla and follicle” in the cul-
tured organs showing the normal cap-like tooth germ,
or the “odontogenic ectomesenchyme” in the samples
with the inhibition of tooth germ development. As
shown in Figure 7G, no significant difference in the
Ki67-positive ratio was observed in any of the objective
areas (DE, DM or SM) between the control mandibles
(Figure 7E) and the cultured mandibles at E10.5 treated
with Prtg AS-S-ODN (Figure 7F). While significant dif-
ferences in cell proliferation were noted between the DE
and SM in the control sampled and in the mandibles
treated with SE-S-ODN, this difference was not
observed in the areas in samples treated with AS-S-
ODN (Figure 7G). No apparent inhibition of cell prolif-
eration by Prtg perturbation was observed in the sam-
ples at day 8 of culture in this study.
Down-regulation of Bmp-4 expression by the depletion of
Prtg mRNA by AS-S-ODN
Based on the findings of the Prtg inhibition assay, we
performed a real-time PCR analysis to examine Bmp-4,
Fgf8, Lef-1, Pitx2 and Shh expression between AS-S-
ODN-treated E10.5 mandibles and the others. These
genes are expressed in mouse E10.5 mandible and are
associated with odontogenesis [24-28]. The samples
treated with S-ODN for 24 hr were used to examine the
changes in gene expression in the early phase after Prtg
inhibition.
Mouse Gapdh was used as an internal control. At
24 hr after AS-S-ODN treatment, Bmp-4 mRNA expres-
sion in the E10.5 mandible was reduced to approxi-
mately 40% by AS-S-ODN treatment, and was
significantly lower with AS-S-ODN treatment than with-
out treatment, than with RS-S-ODN treatment, or with
SE-S-ODN treatment samples (p <0 . 0 5 ,p <0 . 0 5a n d
p < 0.01, respectively; Figure 8). Meanwhile, the expres-
sion levels of F g f 8 ,L e f - 1 ,P i t x 2 ,a n dShh showed no
significant differences following treatment with Prtg
AS-S-ODN (data not shown).
Discussion
This study showed that Prtg, which is a highly expressed
gene in the E10.5 mouse mandible, using a cDNA sub-
traction method between mandibles at E10.5 and E12.0
[9]. The gene belongs to the immunoglobulin superfam-
ily according to a structural analysis, and was expressed
in the early stages of the developing tooth germ. The
temporal and spatial expression of this gene suggested
that this gene is involved in the development of the
mouse lower first molar. This is the first report to
describe the relationship between the expression of Prtg
and tooth morphogenesis.
The amino acid alignment of Prtg is comprised of an
SP, 4 Ig domains, 5 FNIII repeats, a single TM, and a
CD, thereby showing the typical structure of an IgSF.
Treatment with N-glycosidase F revealed that Ptrg is a
highly N-glycosylated transmembrane protein. However,
because the Prtg protein is bigger than the assumed size
even after the treatment with N-glycosidase, this modifi-
cation is also associated with O-glycosylation and phos-
phorylation. The structural characteristics of Prtg are
similar to DCC, Neogenin [17], Punc [18], and Nope
Table 1 The effects of Prtg knockdown on enamel organ
formation in the cultured mandible
Developmental
Stages
Untreated HVJ SE AS*
Bud Cap Bud Cap Bud Cap Bud Cap
Sample No. 0 10 1516 1 8 5
(%) (0) (100) (17) (83) (14) (86) (78) (22)
(*p < 0.05)
The histological analysis was performed to evaluate the effects of Prtg
knockdown on enamel organ formation in the cultured E10.5 mandibles after
S-ODN treatment for 8 days. The development of the enamel organs on day 8
of culture was significantly inhibited.
Figure 8 Prtg knockdown reduces the expression of
odontogenesis-related genes. Bmp-4 expression was significantly
downregulated after 24 hr AS-S-ODN treatment in the cultured
E10.5 mandibles. Significant differences in the transcription activity
are indicated with either single or double asterisks (*p < 0.05, ** p <
0.01). Ut; untreated control sample, AS; samples treated with AS-S-
ODN, RS; samples treated with random sequence-S-ODN, SE;
samples treated with SE-S-ODN.
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Page 9 of 15[19], thus suggesting that they are all members of the
DEAL subfamily.
Some IgSF proteins are important in the early devel-
opmental stage of the central nervous system. Mean-
while, these IgSF proteins are also implicated in various
organs and tissues such as testis (BT-IgSF) [29], intes-
tine (Neogenin) [17] and mesoderm cells (Robo) [30].
Chuong et al. [31] suggested that DCC may be involved
in the differentiation of stem cells within several epithe-
lial tissues. Nierhoff et al. [32] reported that the IgSF
member Nope is expressed in rat fetal liver stem cells,
and this gene might therefore be useful to identify, char-
acterize, and isolate hepatic stem cells from the adult
liver. Recently, diverse functions of DEAL have been
identified, and include cell migration and axon growth
guidance during development of the vertebrate nervous
system [33-37] and the morphogenesis of epithelial tis-
sues and the control of apoptosis in non-neural organi-
zation [17,31-33,38-40]. Therefore, it is likely that Prtg
has multiple functions as a member of the DEAL family,
including cell proliferation and cell differentiation dur-
ing embryogenesis.
The RT-PCR and Western blot analyses showed that
the Prtg mRNA and protein were expressed in the early
developmental stages of tooth germ morphogenesis, as
well as in the central nervous system. In the mouse, we
did not detect Prtg mRNA in any adult tissues except
for the brain, thus suggesting that Prtg function may be
required in some non-neural tissues during organogen-
esis. The ISH and IHC results demonstrated that this
gene was highly expressed in the epithelial and
mesenchymal cells at E10.5, and this expression pattern
is similar to the distribution of the arch ectodermal cells
[14]. The first branchial arch is derived from neural
crest cells [23]. Ptrg is strongly expressed in the first
branchial arch in the early stage of embryogenesis (until
E9.25) [14]. Because the mandible develops from the
first branchial arch, the findings suggest that Prtg might
play a role in the migration of neural crest cells, similar
to the function of the other DEALs during development
of the nervous system [33-37]. Tooth morphogenesis
appears to begin with a signal of an epithelial-mesenchy-
mal interaction [3-5]. The site where the tooth germ is
likely to form is determined by the signal of mesenchy-
mal cells which are derived from craniofacial neural
crest cells [23]. The mesenchymal cells in the early
phase (E10.5 and E12.0) of tooth germ formation were
found to be positive for Prtg. This may indicate that the
expression of Prtg is closely associated with epithelial-
mesenchymal interactions.
An interesting finding in this study revealed that Prtg
was expressed in epithelial cells, including the estimated
tooth germ formation area at E12.0, the epithelial cells
of the tooth bud at E14.0, and the inner enamel
epithelium at E18.0. The DEAL proteins have been
observed in non-neural systems and are involved in the
morphogenesis of epithelial tissues and the control of
apoptosis during organization. In fact, there are reports
describing their role in the differentiation of the intes-
tine epithelium [41,42], and in the budding and branch-
ing of lung alveoli [39]. Therefore, it is reasonable to
consider that Prtg is also involved in the early develop-
ment of odontogenic epithelial tissue. Once the tooth
developmental process is initiated, then Prtg expression
may be dramatically downregulated in these regions. In
this study, AS-S-ODN was employed in an organ culture
system to examine the functional roles of Prtg in the
development of the tooth germ. The development of
tooth germ was arrested at the bud stage when AS-S-
ODN was added to the culture media. However, Prtg
perturbation did not lead to any apparent inhibition of
cell proliferation in this study. The reason for the devel-
opmental arrest of the tooth remains unknown at pre-
sent. It is possible that the result may have been
observed because the comparison was made between
the tooth germs with different developmental stages at
the 8th day after cultivation of the controls or the sam-
ples treated with SE-S-ODN and the samples treated
with Prtg AS-S-ODN. Recently, Wong et al. reported
that Prtg might have the potential to act before the
onset of circulation to coordinate the rate of prolifera-
tion and the time of differentiation between the three
primary germ layers [43]. In our study, the expression
level of Prtg markedly decreased after E12.0 in compari-
son to that at E10.5. Similar results were shown during
nerve development in the study of Wong et al. [43].
Therefore, it seems likely that the Prtg participates in
the development of the tooth germ during the process
of odontogenesis.
Furthermore, Bmp-4 mRNA expression was decreased
following Prtg depletion. This result suggests that the Prtg
is related to the direct or indirect regulation of Bmp-4
gene transcription. Because Bmp-4 plays an important role
during odontogenesis as well as embryogenesis [24,26],
Prtg depletion by treatment with AS-S-ODN may induce
developmental arrest of the tooth germ. However, there
have been no reports thus far that describe the mechanism
of Prtg regulation of Bmp-4 expression. The other genes,
Fgf8, Lef-1, Pitx2, and Shh, also play important roles in
determining and/or budding tooth germ in the early devel-
opment. Bmp-4 induces Lef-1 expression [44]. Pitx2 tran-
scription is partially regulated by Lef1 [45]. Meanwhile,
the Lef-1 expression overlaps that of Pitx2 at approxi-
mately E1.5 after Pitx2 expression, and Pitx2 regulates the
Lef-1 isoform expression [46]. Interactions between these
products are complex, and further studies will likely clarify
the interrelationship between them and their role in devel-
opment. Although Bmp-4 downregulation would be
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significantly affect the expression of these genes in the
early phase (within 24 hr). While Pitx-2 is expressed
within the entire left atrial chamber of E12.5 mouse hearts
[47], the Prtg protein is not detectable within cardiac cells
of the atrial and ventricular chambers from E8.25 to E10.5
mouse hearts [43]. The interaction between Prtg and these
proteins, and signal transduction pathways associated with
Prtg have not been identified so far. Therefore, future stu-
dies will be needed to clarify the interaction between Prtg
and Bmp-4 during signal transduction and subsequent
gene expression, as well as that among the other genes
during tooth germ development.
Alternatively spliced variants were not identified
within the coding region of Prtg cDNA from E10.5 mice
in this study. In contrast, mouse Neogenin (mNeogenin)
has four alternatively spliced exons, three within the
extracellular domain and a fourth within the cytoplas-
mic domain. Three of these alternatively spliced exons
are developmentally regulated [48]. Interestingly, DCC
also contains an alternatively spliced exon within the
extracellular domain [49,50]. The expression of DCC
with this alternative exon is also regulated throughout
embryogenesis, as seen with the alternative forms of
mNeogenin [51]. Thereafter, when more clones from
various embryonic stages are analyzed, alternatively
spliced forms of Prtg may be found in the neuron tissue.
However, Prtg expression was dramatically downregu-
lated in the tooth germ after E12. The regulation of Prtg
function might therefore be different from the mechan-
ism of DCC and Neogenin.
Conclusion
This study demonstrated that Ptrg is preferentially
expressed in the early stage of organogenesis. This study
characterized the expression pattern of Prtg in the devel-
oping tooth germ, and thus shows the possible functional
implications of this gene in tooth germ morphogenesis
through an inhibition assay for Prtg by AS-S-ODN in
organ culture. Prtg, an IgSF family member is involved in
the initial development of the tooth germ and in the dif-
ferentiation of the inner enamel epithelial cells in the
mouse lower first molar. Future investigations of organ
cultures of the mandible earlier than E10.5 are therefore
expected to clarify this process.
Methods
Animals
The embryos of BALB/c mice at E10.5, E12.0, E14.0,
E16.0, and E18.0 after gestation were used in this study.
The adult BALB/c mice were obtained from Charles
River Laboratories (Charles River Japan Incorporated).
Female BALB/c mice (10-30 weeks) were caged together
with male mice. After 3 hr, successful insemination was
determined based on the presence of a post-copulatory
plug in the vagina. The embryonic day was defined as
E0 after the post-copulatory plug was recognized. Male
mice (3, 5, and 10 weeks) were also used to examine the
expression of Prtg. All mouse experiments and housing
were performed in accordance with the guidelines of the
Animal Center of Kyushu University.
cDNA subtraction and cloning procedures
Prtg was identified as a novel gene, termed Clone 15,i n
a previous study [9]. Based on the sequence of a frag-
ment of this gene, 5’-/3’-RACE was performed to deter-
mine the full-length sequence (SMART RACE cDNA
Amplification Kit; Clontech). Prtg DNA sequencing was
performed with the dideoxynucleotide termination
method using a DNA sequencer 373 S (Applied Biosys-
tems). A search of the GenBank online database (using
NCBI/BLAST/blastn suite: BLASTN programs) revealed
no information at that time. In a later search, it corre-
sponded with part of GenBank Accession numbers
AK036172, AK083540, and NM_175485. AK036172
includes a polyadenylation signal site, and NM_175485
includes an arrangement of a signal peptide (SP). The
sequencing data identically correlated to that of the
recently updated NM_175485.4.
Structural analysis based on the amino acid alignment
A domain analysis of the Prtg protein sequence was car-
ried out based on the amino acid alignment using an
NCBI conserved domain search with the online NCBI
program http://www.ncbi.nlm.nih.gov/Structure/cdd/
cdd.shtml. The signal peptides and a transmembrane
region were predicted using the SOSUI system http://
bp.nuap.nagoya-u.ac.jp/sosui/.
Intracellular localization of recombinant Prtg
Three different plasmids expressing an EGFP-fusion pro-
tein were prepared. Prtg cDNA with a full-length, or the
Prtg cDNA with a deleted SP1 or SP2 region were
inserted in pEGFP-N1 vectors (Clontech), as shown in
Figure 2A. These subcloned vectors were termed as Prtg-
full, Ptrg-ΔSP1, and Prtg-ΔSP2. MISK81-5, which is an
oral squamous cell carcinoma cell line established in our
laboratory [22], was stably transfected with Prtg-full,
Prtg-ΔSP1, Prtg-ΔSP2, or an empty vector using Lipofec-
tamine 2000 (Invitrogen). These transfectants were iso-
lated after selection with 800 μl/ml G418 for 2-3 weeks.
Immunofluorescent staining with an anti-cadherin
antibody and Alexa Fluor 594 rabbit anti-mouse IgG
(Invitrogen) was performed on the cells transfected with
the Prtg-full plasmid. The fluorescent images were
observed under a fluorescent microscope and acquired
using the digital imaging software program, AxioVision
version 3.1 (Carl Zeiss).
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Rabbit anti-Prtg polyclonal antibodies were generated
against a synthetic peptide based on the regions as fol-
lows: 1) PKDASESNQRPKRLDSSNAKV (Entrez Protein
database accession number NP_780694 aa 910-930),
2) STPPTSNPLAGGDSDGDAAPKKHGD (aa 1139-
1163), and 3) DAAPKKHGDPAQPLPA (aa 1156-1171).
The first amino acid sequence is present in the extracel-
lular domain near the transmembrane region, whereas
the two latter sequences correspond to sequences in the
cytoplasmic domain. First, three antibodies were tested
for their dye-affinity. The antibody for aa 1156-1171 was
selected and used for all subsequent experiments
because it gave a more specific signal.
Western blot analysis
A Western blot analysis for Prtg protein levels was per-
formed on resolved proteins isolated from the homoge-
nates of E10.5 and E12.0 mandibles and E18.0 tooth
germ. These tissues were lysed in RIPA buffer (50 mM
Tris pH 8.0, 150 mM NaCl, 1% Triton X-100, 1 mM
EDTA pH 8.0, 0.1% SDS) supplemented with a protease
inhibitor cocktail (50 μM), lactacystin (20 μM), and
PMSF. The protein samples were separated on a 7%
SDS-polyacrylamide gel and electrotransferred to an
Immun-Blot PVDF Membrane (Bio-Rad). The mem-
brane was probed with antibody against Prtg for 1 hr at
room temperature, and incubated for 1 hr with second-
ary anti-rabbit IgG conjugated with horseradish peroxi-
dase (Amersham). The membrane was developed using
the enhanced chemiluminescence (ECL) Plus system
(Amersham). Emitted light was detected using a cooled
CCD-camera (LAS-1000), (Fujifilm). Glycosidase diges-
tion was performed with an N-glycosidase F deglycosyla-
tion kit (Roche) according to the manufacturer’s
instructions before loading the samples in the gel.
Temporal expression analysis of Prtg mRNA by semi-
quantitative RT-PCR
Total mRNA was extracted from E10.5, E14.0, and E18.0
mice, and from various organs of the 3-, 5-, or 10-week-
old mice using an SV Total RNA Isolation system
(Promega). Reverse transcription was performed to
synthesize cDNAs using the Superscript III reverse tran-
scriptase (Invitrogen). The cDNAs were amplified by
PCR to compare the expression with the manifestation
quantity. The forward and reverse primer pairs for Prtg
and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) were: Prtg 5’-CGA AGC AAA GCC AGG
AAG TC-3’ and 5’-GCT TGT TGT GAA TCC CTG
AGC G-3’,a n dG A P D H5 ’-ACC ACA GTC CAT GCC
ATC AC-3’ and 5’-TCC ACC ACC CTG TTG CTG
TA-3’. The PCR products were separated by electro-
phoresis on a 2% agarose gel. To confirm that the PCR
products were derived from cDNA and not from geno-
mic DNA, the primer pairs were designed upstream and
downstream of introns.
In Situ Hybridization
The section preparation, the probe labeling, the specifi-
city of the DIG-labeled in situ RNA probes, and ISH
methods were carried out as described in our previous
studies [6,7,12]. Prtg a n t i s e n s ep r o b e sw e r ed e s i g n e d
against a sequence in the C-terminal region and the
3’-UTR corresponding to nucleotide positions 3487 to
4917 (NM_175485.4). A Prtg sense probe was applied to
the tissue specimens as a control. However, no hybridi-
zation signal was detected.
Immunohistochemistry
The preparation of serial cryosections was processed in
t h es a m ew a ya sf o rI S H .A f t e rt h ed r i e dc r y o s e c t i o n s
were rinsed with PBS containing 0.1% Triton X-100 for
10 min, and IHC was performed with a CSA II Biotin-
free Tyramide Signal Amplification System according to
the manufacturer’s instructions (Dako). The primary
anti-Prtg antibody diluted 1:500 in PBS was used. For
the negative control, the application of the primary anti-
body was omitted from the procedure.
Inhibition assay for Prtg by AS-S-ODN in organ culture
The detailed procedures of the inhibition assay for Prtg
by AS-S-ODN in organ culture have been shown in pre-
vious studies [6,7]. Briefly, the mandibles were dissected
from E10.5 embryos. These explants were mounted on a
filter (0.8 μm pore size, Millipore, MA), and then were
incubated in Fitton-Jackson’s modified BGJb medium
(Invitrogen) supplemented with 5% fetal bovine serum
(Filtron, Brooklyn, Australia), 100 μg/ml ascorbic acid
(Invitrogen), and 100 units/ml penicillin/streptomycin
(Invitrogen) in a 5% CO2 atmosphere at 37°C [6,7].
The HVJ-liposomes (GenomeOne series, Ishihara San-
gyo Kaisha, LTD., Osaka, Japan) were purchased for this
study. The HVJ-liposome complex was prepared accord-
ing to the manufacturer’s instructions (Ishihara). ODNs
were: sense-S-ODN (SE-S-ODN): 5’-TGA ATG GCG
CCT CCC GT-3’,a n t i s e n s e - S - O D N( A S - S - O D N ) :5 ’-
ACG GGA GGC GCC ATT CA-3’. The SE/AS-S-ODNs
corresponded to nucleotide positions 181-197 (GenBank
accession number NM_175485.4). The treatment with
AS- or SE-S-ODN or HVJ-liposome alone was per-
formed at 24 hr intervals.
Histological analysis of cultured mandibles
On the 8th day after cultivation, the cultured mandibles
were fixed with 4% paraformaldehyde and embedded in
paraffin to be used for histological analysis. Five-μm-
thick sections were cut in an antero-posterior direction,
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were examined under light microscopy.
Cell proliferation analysis of the cultured organs treated
with AS-S-ODN
In order to address the involvement of the Prtg protein in
tooth morphogenesis, a cell proliferation was analyzed in
the cultured organs treated with AS-S-ODN for Prtg.
Immunohistochemistry using a rabbit polyclonal anti-
body to the Ki67 (Abcam, Cambridge UK) was performed
to evaluate Ki67-positive cells in the DE, DM and SM
areas. More than one hundred objective cells were exam-
ined as a population in at least three different micro-
scopic fields of each area. The number of the stained
cells was divided by the total number of stained and non-
stained target cells to calculate the Ki67-positive ratio.
Effects of Prtg suppression by AS-S-ODN on
odontogenesis-related gene transcription
Real-time quantitative PCR was performed to estimate
the subsequent expression of selected genes using Ther-
mal Cycler Dice Real Time System (TaKaRa, Shiga,
Japan) with SYBR Premix Ex Taq II (TAKARA) accord-
ing to the manufacturer’s instructions. At 24 hr after the
inhibition assay for Prtg by AS-S-ODN in organ culture,
Bmp-4, Fgf8, Lef-1, Pitx2,a n dShh were analyzed in this
study. Gapdh was used as a referable gene. The specific
primer sets were as follows:
Prtg forward 5’-ATC GCA GTA GGC GTT GGC
ATA-3’,
reverse 5’-CGC TGT CTT AGA GGC GGA TGA-3’.
Bmp-4 forward 5’-AGC CGA GCC AAC ACT GTG
AG-3’,
reverse 5’-TCA CTG GTC CCT GGG ATG TTC-3’.
Fgf8 forward 5’-CAT CAA CGC CAT GGC AGA A-3’,
reverse 5’-TCT CCA GCA CGA TCT CTG TGA
ATA C-3’.
Lef1 forward 5’-TCA CTG TCA GGC GAC ACT TC-3’,
reverse 5’-TGA GGC TTC ACG TGC ATT AG-3’.
Pitx2 forward 5’-AGC TGT GCA AGA ATG GCT
TT-3’,
reverse 5’-CAC CAT GCT GGA CGA CAT AC-3’.
Shh forward 5’-AGC AGA CCG GCT GAT GAC TC-3’,
reverse 5’-TCA CTC CAG GCC ACT GGT TC-3’.
Gapdh forward 5’-TGT GTC CGT CGT GGA TCT
GA-3’,
reverse 5’-TTG CTG TTG AAG TCG CAG GAG-3’.
The relative expression levels of each targeted gene were
normalized using the ΔΔCT comparative method, based
on the referable gene threshold cycle (CT) values [52].
Statistical analysis
Significant differences within a group and between
groups were determined by a chi-square test for the
independence of the Prtg inhibition assay, and by
unpaired Student’s t-test or one-way ANOVA with the
Tukey-Kramer comparison test for real-time PCR data
and cell proliferation assay using the Statcel2 software
program. When necessary, Welch’s t-test was used for
unequal variances. A P-v a l u eo fl e s st h a n0 . 0 5o r0 . 0 1
was considered to be statistically significant.
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